Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/17/2000 | US6132722 Recombinant antibody-enzyme fusion proteins |
10/17/2000 | US6132721 Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
10/17/2000 | US6132719 Produced by digesting human fibrinogen with granulocyte elastase and d-domain-containing digestion products produced by digesting human stabilized fibrin with granulocyte elastase |
10/17/2000 | US6132718 Using a vaccine comprising antibodies and anti-idiotype antibodies that mimic an epitope of antigen that is associated with a tumor or infectious agent. |
10/17/2000 | US6132717 Administering to said mammals an endoproteolytically active amount of furin produced by a eukaryotic host cell. |
10/17/2000 | US6132713 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
10/17/2000 | US6131816 Data system with support surfaces for reciprocating data head |
10/17/2000 | US6131578 Inhibitors of UDP-G1cNAc:Ga1β1-3Ga1NAcαR β1-6 N-acetylglucosaminyltransferase (core 2 G1cNAc-T) and use of the inhibitors to prevent or treat cardiomyopathy associated with diabetes |
10/17/2000 | CA2177357C Pna-dna-pna chimeric macromolecules |
10/17/2000 | CA2163781C Method and apparatus for conducting an array of chemical reactions on a support surface |
10/17/2000 | CA2117303C Anti-cancer immunotherapeutic vector constructs |
10/17/2000 | CA2104899C Antibodies to plasmodium falciparum |
10/17/2000 | CA2078703C Process for detecting specific mrna and dna in cells |
10/17/2000 | CA2068320C Production of recombinant human interleukin-1 inhibitor |
10/17/2000 | CA1341123C Filamentous hemagglutinin of b. pertussis |
10/17/2000 | CA1341121C Enod2 gene regulatory region |
10/17/2000 | CA1341119C Human erythroid-specific transcriptional enhancer |
10/17/2000 | CA1341118C Nucleic acid and methods for the synthesis of novel decay accelerating factor compositions |
10/17/2000 | CA1341117C Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, dna fragments and recombinants for use in the production of said cells and plants |
10/17/2000 | CA1341116C Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein |
10/12/2000 | WO2000060126A2 Quantitative assay for expression of genes in microarray |
10/12/2000 | WO2000060125A2 High resolution dna detection methods and devices |
10/12/2000 | WO2000060124A2 Fixed address analysis of sequence tags |
10/12/2000 | WO2000060120A2 Methods of detecting microorganism using immobilized probes |
10/12/2000 | WO2000060118A2 Electrophoretic analysis of target molecules using adapter molecules |
10/12/2000 | WO2000060117A2 Prediction of risk of interstitial lung disease |
10/12/2000 | WO2000060115A2 Method for identifying accessible binding sites on rna |
10/12/2000 | WO2000060114A2 Polynucleotide sequencing using a helicase |
10/12/2000 | WO2000060113A2 Transposon-based genetic marker |
10/12/2000 | WO2000060109A1 Amplification of cyp24 and uses thereof |
10/12/2000 | WO2000060106A1 Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration |
10/12/2000 | WO2000060103A2 Dna construct comprising a cyanophage of cyanobacteria promoter and its use |
10/12/2000 | WO2000060101A1 Metabolic selection markers for plants |
10/12/2000 | WO2000060100A1 Dsp-9 dual-specificity map kinase phosphatase |
10/12/2000 | WO2000060099A1 Dsp-4 dual-specificity map kinase phosphatase |
10/12/2000 | WO2000060098A1 Dsp-7 dual-specificity map kinase phosphatase |
10/12/2000 | WO2000060097A1 Plant rna-directed rna polymerase proteins |
10/12/2000 | WO2000060096A1 Thermostable enzyme having aminotransferase activity and gene encoding the same |
10/12/2000 | WO2000060095A2 Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes |
10/12/2000 | WO2000060094A1 Modified lactococci expressing a catalase and their uses |
10/12/2000 | WO2000060093A1 Linoleate and linolenate-lipoxygenase mutants |
10/12/2000 | WO2000060091A2 Method for selecting recombinase variants with altered specificity |
10/12/2000 | WO2000060090A1 Compounds and methods for the diagnosis and treatment of b. microti infection |
10/12/2000 | WO2000060089A1 Genetic trait breeding method |
10/12/2000 | WO2000060088A2 Plant viral movement protein genes |
10/12/2000 | WO2000060087A2 Cyclin dependent kinase inhibitor genes from plants |
10/12/2000 | WO2000060086A1 Pathogen inducible promoter |
10/12/2000 | WO2000060085A1 Fibroblast growth factor-20 |
10/12/2000 | WO2000060084A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
10/12/2000 | WO2000060083A1 Novel protein associated with cell stress response |
10/12/2000 | WO2000060082A2 Vesicle associated proteins |
10/12/2000 | WO2000060081A1 Dna encoding orphan receptors |
10/12/2000 | WO2000060080A2 Molecules of the immune system |
10/12/2000 | WO2000060079A2 New members of tnf and tnfr families |
10/12/2000 | WO2000060078A2 Latheo encodes a subunit of the origin of recognition complex |
10/12/2000 | WO2000060077A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
10/12/2000 | WO2000060076A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
10/12/2000 | WO2000060075A1 Novel proteins, gene encoding the same and method of utilization thereof |
10/12/2000 | WO2000060074A1 Groups of genes expressed in human dendritic cells |
10/12/2000 | WO2000060073A1 Gene of irg27 polypeptide, antibody against the same and therapeutic utilization thereof |
10/12/2000 | WO2000060072A1 Polynucleotide synthesis using a processing enzyme |
10/12/2000 | WO2000060071A1 Microtubule-associated protein tpx2 |
10/12/2000 | WO2000060070A1 A polypeptide structure for use as a scaffold |
10/12/2000 | WO2000060069A1 A presenilin associated membrane protein and uses thereof |
10/12/2000 | WO2000060068A1 Gene expression base sequences for therapeutic use and drugs for gene therapy |
10/12/2000 | WO2000060066A1 Protein-protein from s. cerevisiae and methods of using same |
10/12/2000 | WO2000060063A1 Lipase variant |
10/12/2000 | WO2000060062A2 Human signal transduction serine/threonine protein kinase |
10/12/2000 | WO2000060061A2 Transgenic plant resistant to mycotoxins and methods |
10/12/2000 | WO2000060060A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
10/12/2000 | WO2000060059A2 Alpha-amylase variants |
10/12/2000 | WO2000060058A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
10/12/2000 | WO2000060057A1 Rat gpr10 |
10/12/2000 | WO2000060056A1 Mouse edg5 gene |
10/12/2000 | WO2000060053A1 Method for producing microbe recombinants (mutualisation or tets's method) |
10/12/2000 | WO2000060052A1 A method for altering the metabolism of plant |
10/12/2000 | WO2000060051A2 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
10/12/2000 | WO2000060050A2 Recombinant influenza viruses for vaccines and gene therapy |
10/12/2000 | WO2000059942A2 Human obesity protein binding protrein-2 homolog and uses thereof |
10/12/2000 | WO2000059938A1 Angiopoietin-like proteins, crisp proteins and polynucleotides encoding same |
10/12/2000 | WO2000059936A1 Human neurogenin 3-encoding nucleotide sequences |
10/12/2000 | WO2000059933A2 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS |
10/12/2000 | WO2000059927A1 Purification of biological preparations |
10/12/2000 | WO2000059919A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
10/12/2000 | WO2000059917A2 Information-carrying and information-processing polymers |
10/12/2000 | WO2000059549A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins |
10/12/2000 | WO2000059548A1 Polyethyleneimine:dna formulations for aerosol delivery |
10/12/2000 | WO2000059537A1 System for efficient secretion of recombinant proteins |
10/12/2000 | WO2000059529A1 Mouse edg1 |
10/12/2000 | WO2000059474A1 Fusogenic lipids and vesicles |
10/12/2000 | WO2000059297A2 Methods for tracking the progression of alzheimer's disease and identifying treatments using transgenic mice |
10/12/2000 | WO2000049132A9 Uses of transgenic animals containing a type x collagen mutant |
10/12/2000 | WO2000037494A3 Chlamydia trachomatis antigens |
10/12/2000 | WO2000036129A8 Enhanced protein production in higher plants by n-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
10/12/2000 | WO2000035940A3 Method and devices for applying substances to a support, especially monomers for the combinatorial synthesis of molecule libraries |
10/12/2000 | WO2000035939A3 Connective tissue growth factor fragments and methods and uses thereof |
10/12/2000 | WO2000034491A3 An improved efficiency agrobacterium-mediated plant transformation method |
10/12/2000 | WO2000034482A3 Novel compounds derived from neisseria meningitidis |
10/12/2000 | WO2000032803A3 Novel nucleic acid transferring agents, compositions containing them and uses |
10/12/2000 | WO2000029582A3 Cell surface receptor antigen vaccines |